Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Current Taxes (2022 - 2024)

Lexeo Therapeutics' Current Taxes history spans 2 years, with the latest figure at $157000.0 for Q4 2023.

  • On a quarterly basis, Current Taxes fell 68.97% to $157000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $157000.0, a 68.97% decrease, with the full-year FY2023 number at $157000.0, down 68.97% from a year prior.
  • Current Taxes hit $157000.0 in Q4 2023 for Lexeo Therapeutics, up from $16000.0 in the prior quarter.
  • Over the last five years, Current Taxes for LXEO hit a ceiling of $506000.0 in Q4 2022 and a floor of $16000.0 in Q3 2023.